Furthermore, compound IV, a pyrazole benzenesulfonamide, exhibited potent inhibition of CA XII with an IC50 of 0.101 μM and notable anticancer efficacy across several tumor cell lines (Ahmed et al., 2023). Here, CA12 is linked to neoplasm.